Posterior Scleritis Following COVID-19 Vaccination: A Case Report.

Ocul Immunol Inflamm

Department of Ophthalmology, University Hospital Hairmyres, Glasgow, UK.

Published: April 2023

Purpose: To report a case of posterior scleritis following COVID-19 vaccination.

Study Design: Case report.

Results: A 78-year-old female presented with headache and right-sided visual loss 10 days after the second dose of COVID-19 vaccine. 'Examination showed disc oedema and a serous retinal detachment. B-scan ultrasound showed thickening of the posterior sclera with retroscleral fluid. CT head with venogram excluded venous sinus thrombosis. The patient's condition improved rapidly with oral corticosteroids with restoration of vision and resolution of disc swelling and serous detachment by 4 weeks.

Conclusions: Posterior scleritis should be considered in patients presenting with headaches and blurred vision following vaccination. Timely diagnosis and treatment with corticosteroids can prevent permanent visual loss.

Download full-text PDF

Source
http://dx.doi.org/10.1080/09273948.2022.2042319DOI Listing

Publication Analysis

Top Keywords

posterior scleritis
12
scleritis covid-19
8
visual loss
8
posterior
4
covid-19 vaccination
4
vaccination case
4
case report
4
report purpose
4
purpose report
4
report case
4

Similar Publications

Analysis of the Incidence of Ocular Extraintestinal Manifestations in Inflammatory Bowel Disease Patients: A Systematic Review.

Diagnostics (Basel)

December 2024

Departamento de Farmacología and CIBERehd, Facultad de Medicina, Universidad de Valencia, Av. Blasco Ibáñez, 15, 46010 Valencia, Spain.

: Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis, primarily affects the gastrointestinal tract. Additionally, extraintestinal manifestations may occur in the liver, musculoskeletal system and eyes. Its etiology remains unknown, and further research is required in order to develop pharmacological drugs which achieve complete remission of the pathology.

View Article and Find Full Text PDF

Developing the biomarker panels and drugs by proteomic analysis for autoimmune uveitis and posterior scleritis.

iScience

December 2024

Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China.

Autoimmune uveitis and posterior scleritis are ocular diseases caused by immune dysregulation. Their pathogenesis remains elusive, and delayed diagnosis can exacerbate vision loss. Our study analyzed proteomic profiles of 190 patients with Behcet's disease uveitis, posterior scleritis, and Vogt-Koyanagi-Harada syndrome.

View Article and Find Full Text PDF

Nodular posterior scleritis is an uncommon inflammatory disorder of the eye characterized by nodular lesions that may be similar to other intraocular conditions such as choroidal melanoma, leading to diagnostic difficulties. This case report and literature review aims to evaluate the demographics, modalities, treatment, and outcomes of nodular posterior scleritis. We describe a 41-year-old female patient who presented with diminished vision in her left eye.

View Article and Find Full Text PDF

: To report a patient with choroidal bulging, sub-retinal fluid, and optic nerve head (ONH) swelling who was finally diagnosed with focal nodular posterior scleritis. : A 51-year-old male patient presented to us with acute painful visual loss of his left eye (LE) from 3 days ago. The best-corrected distance visual acuity (BCDVA) was 20/20 and hand motion (HM) for the right eye (RE) and LE, respectively.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!